Central Nervous System

  • Our CNS pharmacology arm focuses on 3 main therapeutic areas – neurodegenerative diseases, mental health and pain.
  • The MEU has capabilities to perform first-in-human studies in mental health disorders and dementia.
  • Our affiliated key opinion leaders are able to provide the MEU and sponsors with the necessary expertise in protocol development, particularly with regards to pharmacological challenge studies using intravenous and oral compounds.
  • Our access to specialist imaging and psychologists enables us to perform a wide range of pharmacodynamic assessments.